LUMIGAN (Allergan, Inc.)


Welcome to the PulseAid listing for the LUMIGAN drug offered from Allergan, Inc.. This Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: bimatoprost
SUBSTANCE NAME: BIMATOPROST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-09-10
END MARKETING DATE: 0000-00-00


LUMIGAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLUMIGAN from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.1(mg/mL)
START MARKETING DATE: 2010-09-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-3205_87403afb-5e81-49e7-832f-ac98b765ed5c
PRODUCT NDC: 0023-3205
APPLICATION NUMBER: NDA022184

Other BIMATOPROST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.LUMIGAN
LUPIN LIMITEDbimatoprost
Lupin Pharmaceuticals, Inc.bimatoprost
Physicians Total Care, Inc.LUMIGAN
Sandoz IncBimatoprost